SC flays Patanjali for violation of undertaking on claims, ads
The bench also cautioned Patanjali Ayurved and its officers from making any statements adverse to any system of medicine in the media, both print and electronic, in any form as they said in their undertaking before the court earlier
PTI
New Delhi, 27 Feb
Supreme Court on Tuesday came down
heavily on yoga guru Ramdev's Patanjali Ayurved for prima facie violation of
the undertaking given by it in the court about its products and also about
statements claiming their medicinal efficacy.
A bench of justices Hima Kohli and
A Amanullah issued a notice to Patanjali Ayurved and its managing director
asking why contempt proceedings should not be initiated against them.
The bench also cautioned Patanjali
Ayurved and its officers from making any statements adverse to any system of
medicine in the media, both print and electronic, in any form as they said in
their undertaking before the court earlier.
On 21 November last year, the
counsel representing the company had assured the apex court that henceforth
there shall not be any violation of law, especially relating to advertising or
branding of products, and no casual statements claiming medicinal efficacy of
Patanjali products or against any system of medicine will be released to the
media in any form.
The apex court had then cautioned
the company, co-founded by Ramdev and dealing in herbal products, against
making "false" and "misleading" claims in advertisements
about its medicines as cure of several diseases.
The top court is hearing a plea of
the Indian Medical Association (IMA) alleging a smear campaign by Ramdev
against the vaccination drive and modern medicines.
Leave a Reply
Your email address will not be published. Required fields are marked *